Volunteer for Research
Our team is actively recruiting for a number of clinical trials. Please contact us to volunteer.
Vaccine Testing Center
89 Beaumont Avenue
Now Recruiting: Outpatient Dengue Vaccine Study Starting in Early 2014
Title: A Phase I Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection with Attenuated DENV--2, rDEN2D30-7169.
Background: Dengue fever is a viral illness that is transmitted by several mosquito species. 50-100 million cases of Dengue fever are reported worldwide every year. There are four types of Dengue virus. Infection with one type of virus may provide long term immunity to that type, but not for the other three types. Currently, there is no vaccine available to prevent Dengue fever.
Clinical Trial: The UVM VTC is conducting a trial of a single Dengue vaccine that may provide immunity against all four types of Dengue virus. The study includes second vaccination day six months after initial vaccination. The primary goals of the trial are to evaluate:
- the safety of the vaccine
- how well the vaccine promotes antibody production
Interested? Contact us at 802-656-0013 or email@example.com for more information.
Frequently Asked Questions about the Dengue Vaccine Study (PDF)
Last modified January 09 2014 03:50 PM